Disclaimer

Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.

Limited by Federal (or United States) law to investigational use only.
Continue To Site

You are switching to a website for another country and will be subject to the terms and policies therein. Products on that website may or may not be available or approved for your location. Please contact your Foldax representative if you have questions about the availability of products in your location. By continuing, you acknowledge and agree to the terms of this notice.

Go Back
Continue
Home
Our Technology
Clinical Evidence
For Patients
About
News
Partnerships
Contact
Our Technology
Clinical Evidence
Patients
About
News
Partnerships
US
IN
Contact Us

News & Resources

Explore the latest information on Foldax® in the collection of press releases, peer-reviewed publications, presentations, and articles that highlight our commitment to transforming cardiovascular care through TRIA™ heart valves.

Press Releases
Publications
Presentations
Articles

Recent

Press Releases

View All
Foldax Announces Positive One-Year Data on TRIA™ Mitral Valve
Foldax® Secures Approval for TRIA™ Mitral Heart Valve in India
Foldax® Reports Positive Clinical Results for TRIA Mitral Surgical Heart Valve Using Novel LifePolymer Material

Publications

View All
One-Year Results from a Multi-Center Trial of a Polymer Surgical Mitral Valve:  Insights into New Technology
Assessment of a Siloxane Poly(urethane-urea) Elastomer Designed for Implantable Heart Valve Leaflets
Preliminary Evaluation of a Novel Polymeric Valve Following Surgical Implantation for Symptomatic Aortic Valve Disease

Presentations

View All
NY Valves 2024: Innovation With A Novel Polymer Heart Valve (TRIA™) Portfolio
EACTS 2024: An Innovative Robotically Manufactured Polymer Valve Establishes Promising Early Clinical Results
NY Valves 2024 Foldax Presentation: Challenging Case: First Treatment with FOLDAX TRIA ™ Surgical Mitral Valve for Rheumatic Heart Disease (RHD)

Articles

View All
Foldax®: Addressing the Need for Better Mitral Valve Replacement
MedTech Strategist Article: Foldax® advances the Next Big Thing in Heart Valves: Robotic Manufacturing
Reinventing the Artificial Heart Valve

Videos

Future of Heart Valves
Robotic Manufacturing
Foldax® Animation
TRIA™ Valves: A Revolution in Heart Valve Technology

Press Releases

Foldax Announces Positive One-Year Data on TRIA™ Mitral Valve
Foldax® Secures Approval for TRIA™ Mitral Heart Valve in India
Foldax® Reports Positive Clinical Results for TRIA Mitral Surgical Heart Valve Using Novel LifePolymer Material
TRIA™ Polymer Surgical Valves Surpass 200 Patient Life Years
Foldax® Signs Manufacturing Agreement with Dolphin Life Science India LLP
Foldax® Announces Completion of Enrollment in India Clinical Trial Evaluating TRIA™ Polymer Surgical Mitral Heart Valve
First Patients Outside of U.S. Treated with TRIA™ Polymer Surgical Mitral Heart Valve
Foldax® Receives Full Ownership Rights to Proprietary Polymer Patent Portfolio
First Clinical Study on TRIA™️ Biopolymer Heart Valve Shows Excellent One-Year Performance
Foldax Announces Medical Device Veteran, Greg Casciaro, as New CEO
First Patients Outside of U.S. Treated with TRIA™️ Biopolymer Surgical Aortic Heart Valve in India Clinical Trial
Foldax® Presents Positive Animal Study Data at 2022 CRT Meeting
Foldax® Announces Addition of Scott Huennekens to its Board of Directors
Foldax® Receives Approval for Clinical Trial of TRIA™️ Biopolymer Surgical Aortic Heart Valve in India
Foldax Completes Enrollment in Early Feasibility Study for TRIA Biopolymer Surgical Aortic Heart Valve
Foldax® Announces Successful First Human Use of TRIA™️ Biopolymer Mitral Heart Valve
Foldax® Named Among Fierce Medtech’s “Fierce 15” Companies of 2020
Foldax® Biopolymer Shown to Possess Ideal Properties for Heart Valve in New Published Paper
Foldax® Receives FDA IDE Approval for Biopolymeric Mitral Heart Valve Clinical Study
Foldax® Receives FDA Approval to Expand Clinical Study of Novel Biopolymer Aortic Heart Valve
Foldax® Named Cardiovascular Device Company of the Year by MedTech Outlook
Foldax® Strengthens Scientific and Medical Advisory Boards
Foldax® Named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020
Heart Valve Innovator Foldax Closes $20 Million Financing
Foldax® Wins 2020 MedTech Breakthrough Award for Cardiovascular Technology Innovation
Foldax® Completes Enrollment in TRIA™ LifePolymer Early Feasibility Study
Foldax® TRIA™ LifePolymer Heart Valve Honored with Best Innovation Award at Cardiovascular Research Technology (CRT) 2020
Best Innovations Competition Winners at Cardiovascular Research Technology (CRT) 2020 by CRTonline.org
Foldax® Announces First Worldwide Implant of the TRIA™ Heart Valve
Foldax® Announces FDA Approval to Begin an Early Feasibility Study of the TRIA™ Heart Valve
Our TechnologyClinical EvidencePatientsAboutNewsPartnershipsContact
Foldax® is reinventing every aspect of the heart valve – from material to design to manufacturing – to develop surgical and transcatheter valves designed to last a lifetime addressing historical tradeoffs between tissue and mechanical valves.

For more information on current clinical investigations, please go to: ClincialTrials.gov

TRIA™ Heart Valves are Investigational devices. Limited by Federal (or United States) law to investigational use. TRIA™ Mitral Valves are approved for use in India by CDSCO

Information contained on this website is for reference only.
Clinical References
Privacy Policy
Terms of Use
LA-0096 Rev. B